Charles Protano

Charles Protano is an accomplished professional in the pharmaceutical industry, currently serving as the Director of CMC at Amarin Corporation since July 2019. With extensive experience ranging from roles such as Principal Scientist in Analytical Development at Ferring Pharmaceuticals to Development Investigator at OSI-Astellas Pharma, Charles has a proven track record in drug product development, regulatory compliance, and supply chain management. Notably, Charles has led cross-functional teams to achieve successful NDA submissions and product launches, managed global CDMO partnerships, and optimized operational efficiencies across various organizations. Charles holds an M.S. in Chemistry from New York University - Polytechnic School of Engineering and a B.S. in Chemistry from SUNY Oneonta.